COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC MACULAR EDEMA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150274841A1
SERIAL NO

14669607

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are compositions comprising one or more antibodies that specifically bind active plasma kallikrein (e.g., human plasma kallikrein) and methods of using such compositions for the treatment of retinal diseases, such as diabetic macular edema.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Conley, Gregory P Arlington, US 9 37
Nixon, Andrew Hanover, US 38 355
Sexton, Daniel J Melrose, US 58 509

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation